Stantec (STN) Q2 2026 earnings review
Record Margins Mask a Stalling U.S. Engine and Cash Flow Squeeze
Stantec delivered a classic margin-expansion story this quarter, but beneath the surface, cracks in organic growth are appearing. While total net revenue climbed 11.5% and Adjusted EBITDA margins hit a stellar 18.7%, the top-line quality is mixed. The Global Water segment remains an absolute powerhouse, but U.S. organic growth completely stalled (0.0%), contradicting management's prior narrative of massive infrastructure tailwinds. Furthermore, operating cash flows severely decoupled from net income, halving year-over-year due to working capital drag. On the capital allocation front, the decision to deploy $175.9M into share buybacks marks a notable shift for the historically M&A-focused firm.
🐂 Bull Case
Adjusted EBITDA margins surged 90 basis points to 18.7%. The company successfully reduced administrative and marketing expenses by 110 basis points as a percentage of net revenue, proving that operational scale and real estate optimizations are flowing to the bottom line.
Contract backlog accelerated to $9.2 billion (+17.5% YoY), representing 13 months of work. The Global region continues to outperform with nearly 25% organic backlog growth.
🐻 Bear Case
Despite management's previous confidence in U.S. momentum, Q2 organic growth in the U.S. hit exactly 0.0%. Deferred client capital investments are clearly taking a toll.
Operating cash flows dropped by $118.4M year-to-date. Net working capital is consuming cash to support acquired revenue, driving Days Sales Outstanding (DSO) up to 75 days.
⚖️ Verdict: ⚪
Neutral. The margin execution and backlog growth are outstanding. However, a 0.0% organic print in the critical U.S. market, a retraction in Infrastructure, and deteriorating cash conversion warrant caution until revenue generation normalizes.
Key Themes
U.S. Organic Growth Hits a Wall
Decelerating. After previously moderating expectations, U.S. organic net revenue growth completely stalled at 0.0% in Q2. Management cited the deferral of public and private capital investment decisions and the rescheduling of large project milestones. This contradicts the bullish narrative surrounding massive IIJA public funding tailwinds that management championed in prior quarters.
Operating Cash Flow Divergence
Reversing. A major red flag has emerged on the cash flow statement. Year-to-date Net Income grew 11% to $261.1M, but Operating Cash Flow plummeted 50% from $234.7M to $116.3M. Management points to the required investment in net working capital to support acquisition growth and the residual friction of integrating the Page acquisition. DSO climbed to 75 days, hitting the upper boundary of internal targets.
Infrastructure Segment Retracts
Reversing. The Infrastructure business operating unit—Stantec's second-largest segment—posted a 1.1% organic retraction in Q2. This was driven by the wind-down of significant transit and roadway projects in Canada and the U.S. without sufficient new project ramp-ups to offset the decline.
Global Water Segment Dominance
Accelerating. The Water business remains Stantec's most reliable growth engine, posting 11.8% organic net revenue growth in Q2. Growth is anchored by long-term framework agreements (such as the UK AMP8) and sustained public sector investments in water infrastructure across Australia and New Zealand.
Mission-Critical Technology and Data Centers
Stable. The Buildings business continues to benefit from the AI and semiconductor boom. During the quarter, Stantec won architecture and engineering services for a 300,000-square-foot Class 100 cleanroom fit-out for a multibillion-dollar semiconductor manufacturing facility, and was selected to design Meta's $13 billion data center in Alberta. These highly complex, mission-critical environments provide high-margin, sticky revenue.
Operational Leverage and Margin Expansion
Accelerating. Stantec successfully squeezed more profit out of its revenue base. Administrative and marketing expenses dropped by 110 basis points as a percentage of net revenue (from 37.5% to 36.4%). This was achieved through real estate optimization (higher utilization and reduced occupancy costs) and tight discretionary spending control, driving the Adjusted EBITDA margin to 18.7%.
Capital Allocation Shift: Buybacks Activated
Reversing. Management historically insisted that M&A was the ultimate priority for capital allocation. However, in the first half of 2026, Stantec actively deployed $175.9 million to repurchase 1.66 million shares under its NCIB. This signals that management views its own equity as highly attractive relative to current M&A targets in a frothy private market.
Other KPIs
Accelerating. Backlog grew 17.5% YoY, representing roughly 13 months of work. This includes robust 7.0% organic growth, heavily concentrated in the Global region (+24.7% organically) and the Water business.
Stable. The leverage ratio remains healthy and identical to the December 2025 level. This sits comfortably within the internal target range of 1.0x to 2.0x, leaving ample dry powder for future acquisitions despite the recent $175.9M outlay for share repurchases.
Guidance
Accelerating. Based on strong H1 execution, management raised both the bottom and top ends of the target range (previously 17.6% to 18.2%). This implies confidence that the SG&A efficiencies achieved in H1 are structural and sustainable.
Stable. The absolute growth range was reaffirmed, but management refined the organic growth expectation to 'mid-single digits' (a subtle walk-back from 'mid- to high-single digits' mentioned in previous periods), reflecting the 0.0% U.S. organic print in Q2.
Stable. Management maintained its forecast for solid double-digit bottom-line growth, heavily supported by the raised EBITDA margin expectations and a marginally lower share count following recent buybacks.
Key Questions
U.S. Organic Growth Timeline
U.S. organic growth hit 0.0% this quarter due to delayed capital decisions. What exact leading indicators or client behaviors do you need to see to give you confidence that this segment will re-accelerate in the back half of the year?
Working Capital Drag
Operating cash flow is down over $118 million year-to-date due to working capital builds and Page integration friction. Do you expect this to reverse in H2, and will full-year free cash flow conversion hit historical norms?
Infrastructure Replenishment
With the Infrastructure segment shrinking organically due to project wind-downs, how does the current pipeline of infrastructure bids compare to the revenue rolling off, and when will segment growth flip positive?
Capital Allocation Strategy
You repurchased $176 million in stock this year. Does this aggressive use of the NCIB reflect a structural shift in how you view Stantec's valuation versus private market M&A targets?